Keratoprosthesis in dry eye disease

被引:3
|
作者
Sharma, Supriya [1 ]
Donthineni, Pragnya Rao [2 ]
Iyer, Geetha [3 ]
Chodosh, James [4 ]
de la Paz, Maria Fideliz [5 ]
Maskati, Quresh [6 ]
Srinivasan, Bhaskar [3 ]
Agarwal, Shweta [3 ]
Basu, Sayan [2 ,7 ,9 ]
Shanbhag, Swapna S. [2 ,8 ]
机构
[1] Shantilal Shanghvi Eye Inst, Cornea & Anterior Segment Serv, Mumbai, Maharashtra, India
[2] LV Prasad Eye Inst, Shantilal Shanghvi Cornea Inst, Hyderabad, Telangana, Pakistan
[3] Sankara Nethralaya, Med Res Fdn, CJ Shah Cornea Serv, Dr G Sitalakshmi Mem Clin Ocular Surface Disorders, Chennai, Tamil Nadu, India
[4] Univ New Mexico, Dept Ophthalmol & Visual Sci, Sch Med, Albuquerque, NM USA
[5] Oftalvist Barcelona, Barcelona, Spain
[6] Maskati Eye Clin, Mumbai, Maharashtra, India
[7] LV Prasad Eye Inst, Ctr Ocular Regenerat CORE, Prof Brien Holden Eye Res Ctr BHERC, Hyderabad, Telangana, Pakistan
[8] LV Prasad Eye Inst, Shantilal Shanghvi Cornea Inst, Hyderabad 500034, Telangana, India
[9] LV Prasad Eye Inst, Prof D Balasubramanian Chair Eye Res, Prof Brien Holden Eye Res Ctr BHERC, Hyderabad 500034, India
关键词
Chronic cicatrizing conjunctivitis; dry eye disease; keratoprosthesis; limbal stem cell deficiency; ocular chemical burns; mucous membrane pemphigoid; Stevens-Johnson syndrome; OSTEO-ODONTO-KERATOPROSTHESIS; LONG-TERM OUTCOMES; OCULAR SURFACE DISEASE; BOSTON KERATOPROSTHESIS; MICOF KERATOPROSTHESIS; VISUAL REHABILITATION; I KERATOPROSTHESIS; SURGICAL TECHNIQUE; END-STAGE; COMPLICATIONS;
D O I
10.4103/IJO.IJO_2817_22
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Bilateral corneal blindness with severe dry eye disease (DED), total limbal stem cell deficiency with underlying corneal stromal scarring and vascularization, combined with adnexal complications secondary to chronic cicatrizing conjunctivitis is a highly complex situation to treat. In such eyes, procedures such as penetrating keratoplasty alone or combined with limbal stem cell transplantation are doomed to fail. In these eyes, keratoprosthesis (Kpro) or an artificial cornea is the most viable option, eliminating corneal blindness even in eyes with autoimmune disorders such as Stevens-Johnson syndrome, ocular mucous membrane pemphigoid, Sjogren's syndrome, and nonautoimmune disorders such as chemical/thermal ocular burns, all of which are complex pathologies. Performing a Kpro in these eyes also eliminates the need for systemic immunosuppression and may provide relatively early visual recovery. In such eyes, the donor cornea around the central cylinder of the Kpro needs to be covered with a second layer of protection to avoid desiccation and progressive stromal melt of the underlying cornea, which is a common complication in eyes with severe DED. In this review, we will focus on Kpro designs that have been developed to survive in eyes with the hostile environment of severe DED. Their outcomes in such eyes will be discussed.
引用
收藏
页码:1154 / 1166
页数:13
相关论文
共 50 条
  • [1] The Boston Keratoprosthesis Type II: The Massachusetts Eye and Ear Infirmary Experience
    Pujari, Siddharth
    Siddique, Sana S.
    Dohlman, Claes H.
    Chodosh, James
    CORNEA, 2011, 30 (12) : 1298 - 1303
  • [2] Contact lenses in dry eye disease and associated ocular surface disorders
    Chaudhary, Simmy
    Ghimire, Deepak
    Basu, Sayan
    Agrawal, Vinay
    Jacobs, Deborah S.
    Shanbhag, Swapna S.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (04) : 1142 - 1153
  • [3] Keratoprosthesis in Autoimmune Disease
    Ciralsky, Jessica
    Papaliodis, George N.
    Foster, C. Stephen
    Dohlman, Claes H.
    Chodosh, James
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2010, 18 (04) : 275 - 280
  • [4] Dry eye disease in head and neck cancer patients undergoing radiotherapy
    Soni, Meenal
    Walia, Shweta
    Jain, Preety
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (04) : 1556 - 1560
  • [5] Surgical Procedures in the Treatment of Dry Eye Disease
    Moller-Hansen, Michael
    Utheim, Tor Paaske
    Heegaard, Steffen
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 39 (10) : 692 - 698
  • [6] A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel
    Rodriguez-Garcia, Alejandro
    Babayan-Sosa, Alejandro
    Ramirez-Miranda, Arturo
    Santa Cruz-Valdes, Concepcion
    Hernandez-Quintela, Everardo
    Hernandez-Camarena, Julio C.
    Ramos-Betancourt, Nallely
    Velasco-Ramos, Regina
    Ruiz-Lozano, Raul E.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 1331 - 1355
  • [7] Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India
    Iyer, Geetha
    Srinivasan, Bhaskar
    Agarwal, Shweta
    Ravindran, Ramya
    Rishi, Ekta
    Rishi, Pukhraj
    Krishnamoorthy, Sripriya
    OCULAR SURFACE, 2019, 17 (01) : 50 - 54
  • [8] The evaluation of dry eye mobile apps for screening of dry eye disease and educational tear event in Japan
    Uchino, Miki
    Kawashima, Motoko
    Uchino, Yuichi
    Suzuki, Natume
    Mitamura, Hiroto
    Mizuno, Miki
    Hori, Yuichi
    Yokoi, Norihiko
    Tsubota, Kazuo
    OCULAR SURFACE, 2018, 16 (04) : 430 - 435
  • [9] The epidemiology of dry eye disease in the UK: The Aston dry eye study
    Vidal-Rohr, M.
    Craig, J. P.
    Davies, L. N.
    Wolffsohn, J. S.
    CONTACT LENS & ANTERIOR EYE, 2023, 46 (03)
  • [10] The Boston Keratoprosthesis Type I in Mucous Membrane Pemphigoid
    Palioura, Sotiria
    Kim, Bryan
    Dohlman, Claes H.
    Chodosh, James
    CORNEA, 2013, 32 (07) : 956 - 961